Demis Lipe

Assistant Professor

The University of Texas MD Anderson Cancer Center

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Demis Lipe is an Assistant Professor at the University of Texas MD Anderson Cancer Center, USA. His research focuses on the intersection of oncology and emergency medicine, particularly regarding cardiotoxicity associated with immune checkpoint inhibitors and effective management of cancer-related pain. Recent publications include systematic reviews and studies on the complications arising in cancer patients and the evolving treatment paradigms in acute oncologic care.

Articles (11)

Year:

2024

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (4)

Patrick Chaftari

Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Aiham Qdaisat

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Nicolas Palaskas

Assistant Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Cielito Reyes-Gibby

Associate Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Demis Lipe

Research Interests

Explore related searches

Contact this professor

About

Articles (11)

Myocarditis, Myositis, and Myasthenia Gravis Overlap Syndrome Associated with Immune Checkpoint Inhibitors: A Systematic Review

Characteristics and Outcomes of Patients with Cancer Pain Placed in an Emergency Department Observation Unit

The Value Proposition of Observation Medicine in Managing Acute Oncologic Pain

Outcomes of Patients Placed in an Emergency Department Observation Unit of a Comprehensive Cancer Center

A modified emergency severity index level is associated with outcomes in cancer patients with COVID-19

Cardiotoxicity of Immune Checkpoint Inhibitors: Beyond Myocarditis

Carotid Blowout Syndrome in the Emergency Department: A Case Report and Review of the Literature

The evolving landscape of chimeric antigen receptor T-cell therapy associated cardiotoxicity

A Model Oncologic Emergency Medicine Curriculum for Residency Training

CAR-T and checkpoint inhibitors: toxicities and antidotes in the emergency department

Cardiotoxicity associated with immune checkpoint inhibitors and CAR T-cell therapy

Collaborators (4)

Patrick Chaftari

Aiham Qdaisat

Nicolas Palaskas

Cielito Reyes-Gibby

Make your next move.